Furthermore, BK channels are implicated in various neurological disorders beyond FXS, including Parkinson’s and Alzheimer’s diseases, highlighting the vast therapeutic potential of this class of drugs [173]. The gene discussed is KCNMA1; the disease is fragile X syndrome.